Published in Blood Weekly, February 9th, 2012
"The adhesion, proliferation, and differentiation of BMSCs were demonstrated by (3-{4,5-dimethylthiazol-2yl}-2,5-diphenyl-2H-tetrazoliumbromide) assay, immunohistochemical staining, and scanning electron microscopy in vitro. Cell survival was tracked via...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2012-02-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.